Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan · Delayed Price · Currency is TWD 131.00
+2.50 (1.95%)
At close: Mar 6, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 6.73 billion as of March 6, 2026. Its market cap has increased by 99.47% in one year.
Market Cap
6.73B
Enterprise Value
6.34B
Revenue
7.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
131.00
Market Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 6.73B, an increase of 222.11%. That is a compound annual growth rate of 10.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.73B | 17.49% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Techzone Technology Materials | 6.89B |
| Brogent Technologies | 6.82B |
| Hi-Lai Foods | 6.82B |
| Gus Technology | 6.82B |
| Gudeng Equipment Co., LTD. | 6.81B |
| Mycenax Biotech | 6.77B |
| Firich Enterprises | 6.68B |
| Yeh Chiang Technology | 6.65B |